Anticorps Polyclonal de lapin anti-OS9

• Phare
• Validé par KD/KO

OS9 Polyclonal Antibody for WB, IHC, IF/ICC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain et plus (1)

Applications

WB, IHC, IF/ICC, ELISA

Conjugaison

Non conjugué

Publications(10)

N° de cat : 10061-1-AP

Synonymes

Amplified in osteosarcoma 9, Protein OS-9

---

Galerie de données de validation

• 

  WB analysis of HEK-293 using 10061-1-AP

  HEK-293 cells were subjected to SDS PAGE followed by western blot with 10061-1-AP (OS9 antibody) at dilution of 1:300 incubated at room temperature for 1.5 hours.

• 

  WB analysis of MCF-7 using 10061-1-AP

  WB result of OS9 antibody (10061-1-AP; 1:600; incubated at room temperature for 1.5 hours) with sh-Control and sh-OS9 transfected MCF-7 cells.

• 

  WB analysis of HeLa using 10061-1-AP

  HeLa cells were subjected to SDS PAGE followed by western blot with 10061-1-AP (OS9 antibody) at dilution of 1:300 incubated at room temperature for 1.5 hours.

• 

  IHC staining of human lung cancer using 10061-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung cancer tissue slide using 10061-1-AP (OS9 antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human lung cancer using 10061-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung cancer tissue slide using 10061-1-AP (OS9 antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human prostate cancer using 10061-1-AP

  Immunohistochemical analysis of paraffin-embedded human prostate cancer using 10061-1-AP (OS9 antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human prostate cancer using 10061-1-AP

  Immunohistochemical analysis of paraffin-embedded human prostate cancer using 10061-1-AP (OS9 antibody) at dilution of 1:50 (under 40x lens).

• 

  IF Staining of HeLa using 10061-1-AP

  Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using OS9 antibody (10061-1-AP) at dilution of 1:400 and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2).

---

Applications testées

• Résultats positifs en WB: cellules HEK-293, cellules HeLa, cellules MCF-7
• Résultats positifs en IHC: tissu de cancer du poumon humain, tissu de cancer de la prostate humain; il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
• Résultats positifs en IF/ICC: cellules HeLa,

Dilution recommandée

• Western Blot (WB): WB : 1:200-1:1000
• Immunohistochimie (IHC): IHC : 1:50-1:500
• Immunofluorescence (IF)/ICC: IF/ICC : 1:200-1:800

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• KD/KO: See 4 publications below
• WB: See 10 publications below
• IF: See 1 publications below

Informations sur le produit

10061-1-AP cible OS9 dans les applications de WB, IHC, IF/ICC, ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Réactivité citée: Humain, souris
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: OS9 Protéine recombinante Ag0106
• Nom complet: osteosarcoma amplified 9, endoplasmic reticulum associated protein
• Masse moléculaire calculée: 76 kDa
• Poids moléculaire observé: 73 kDa
• Numéro d’acquisition GenBank: BC000532
• Symbole du gène: OS9
• Identification du gène (NCBI): 10956
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS with 0.02% sodium azide and 50% glycerol
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

OS-9 is a ubiquitously expressed ensoplasmic reticulum (ER)-associated protein originally identified as being amplified in certain osteosarcomas. It functions in ER quality control and ER-associated degradation (ERAD). There are three isoforms of this protein: OS-9.1, OS-9.2 and OS-9.3. The longest isoform, OS-9.1, contains 667 aa, OS-9.2 lacks aa 535-589, whereas OS-9.3 lacks aa 456-470 and 535-589. OS-9.1 and OS-9.2 are N-glycosylated, ubiquitously expressed in human tissues, and amplified in tumors. Isoform 2 is the major isoform detected in all cell types examined. This antibody can recognize all three isoforms of OS-9.

Publications

Species	Application	Title
human	WB	Nat Cell Biol; OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD.; Authors - Christianson John C JC ; KD Validated
Mouse	WB	Sci Adv; Adult-onset obesity is triggered by impaired mitochondrial gene expression.; Authors - Kara L Perks
human	WB,IF	J Biol Chem; OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum.; Authors - Wang Yan Y ; KD Validated
human	WB	J Biol Chem; Human OS-9, a lectin required for glycoprotein endoplasmic reticulum-associated degradation, recognizes mannose-trimmed N-glycans.; Authors - Hosokawa Nobuko N
human	WB	J Biol Chem; Human XTP3-B forms an endoplasmic reticulum quality control scaffold with the HRD1-SEL1L ubiquitin ligase complex and BiP.; Authors - Hosokawa Nobuko N
human	WB	J Biol Chem; SEL1L protein critically determines the stability of the HRD1-SEL1L endoplasmic reticulum-associated degradation (ERAD) complex to optimize the degradation kinetics of ERAD substrates.; Authors - Iida Yasutaka Y ; KD Validated

{{ptg:RelatedPrimaryAntibodies}}